Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Sanofi SA    SNY   US80105N1054

SANOFI SA (SNY)

6
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

The company operates through the following segments: Pharmaceuticals, Human Vaccines and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing.

The Animal Health segment comprises the research, development, production and marketing activities for vaccines.

It offers a range of medicines and vaccines on animal species.

The company was founded in 1994 and is headquartered in Paris, France.
Managers
NameAgeSinceTitle
Igor Landau, MBA702004Member-Supervisory Board
Robert Castaigne, PhD682000Independent Director
Thierry M. Desmarest692000Director
Jean-René Fourtou752004Independent Director
Claudie Haigneré MD, PhD572008Independent Director
Uwe Bicker PhD, MD692008Independent Director
Karen Linehan551996Senior VP-Legal Affairs & General Counsel
Jérôme Contamine562009Chief Financial Officer & Executive Vice President
Roberto Pucci512009Senior Vice President-Human Resources
Gérard van Kemmel, MBA752003Independent Director
Shareholders
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
GLAXOSMITHKLINE P..
BAYER AG
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
ACTAVIS PLC
TEVA PHARMACEUTIC..
ALLERGAN, INC.
SHIRE PLC
VALEANT PHARMACEU..
TAKEDA PHARMACEUT..
REGENERON PHARMAC..
CSL LIMITED
Sector Pharmaceuticals
Company contact information
Sanofi
54, rue La Boétie
8ème arrondissement
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.43.03
Web : www.sanofi.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF